An abiotic fluorescent probe for cardiac troponin I.

The first ratiometric fluorescent reporter was designed for the detection of cardiac troponin I (cTnI), a key protein elicited during cardiac muscle cell death. In designing this abiotic fluorescent probe, docking simulation studies were performed to predict the probe/protein interactions along the solvent exposed regions of cTnI. Simple cuvette titration experiments in aqueous buffered solution indicate remarkable selectivity for cardiac troponin in the clinically relevant nM region versus skeletal troponin.

[1]  M. Heagy,et al.  An organic white light-emitting dye: very small molecular architecture displays panchromatic emission. , 2010, Chemical communications.

[2]  M. Heagy,et al.  Dual fluorescent N-aryl-2,3- naphthalimides: applications in ratiometric DNA detection and white organic light-emitting devices. , 2010, Organic letters.

[3]  Philip S Low,et al.  Immunomagnetic diffractometry for detection of diagnostic serum markers. , 2007, Journal of the American Chemical Society.

[4]  Tina M. Battaglia,et al.  Quantitative measurement of cardiac markers in undiluted serum. , 2007, Analytical chemistry.

[5]  M. Heagy,et al.  Toward intrinsically fluorescent proteomimetics: fluorescent probe response to alpha helix structure of poly-gamma-benzyl-L-glutamate. , 2006, Bioorganic & medicinal chemistry letters.

[6]  Joonhyung Lee,et al.  Detection of folate binding protein with enhanced sensitivity using a functionalized quartz crystal microbalance sensor. , 2006, Analytical chemistry.

[7]  Andrew D. Hamilton,et al.  Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-xL , 2005 .

[8]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[9]  C. Mirkin,et al.  Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Hooper,et al.  Biochemical markers of myocardial injury. , 2004, British journal of anaesthesia.

[11]  Manuel E Patarroyo,et al.  An alpha helix conformationally restricted peptide is recognized by cervical carcinoma patients' sera. , 2003, Journal of medicinal chemistry.

[12]  Yuichiro Maéda,et al.  Structure of the core domain of human cardiac troponin in the Ca2+-saturated form , 2003, Nature.

[13]  D. Samuel,et al.  A quantitative immuno-PCR assay for the detection of mumps-specific IgG. , 2002, Journal of immunological methods.

[14]  James McCord,et al.  Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I , 2001, Circulation.

[15]  T. Soukka,et al.  Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology. , 2001, Clinical chemistry.

[16]  J. Ornato,et al.  Ability of troponin I to predict cardiac events in patients admitted from the emergency department. , 2000, Journal of the American College of Cardiology.

[17]  A. Wu,et al.  Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. , 1998, Clinical chemistry.

[18]  R. Zeillinger,et al.  Prostate specific antigen (PSA) in breast and ovarian cancer. , 1997, Anticancer research.